Literature DB >> 27562500

Transitioning from Targeted to Comprehensive Mass Spectrometry Using Genetic Algorithms.

Jacob D Jaffe1, Caitlin M Feeney2,3, Jinal Patel2, Xiaodong Lu2, D R Mani2.   

Abstract

Targeted proteomic assays are becoming increasingly popular because of their robust quantitative applications enabled by internal standardization, and they can be routinely executed on high performance mass spectrometry instrumentation. However, these assays are typically limited to 100s of analytes per experiment. Considerable time and effort are often expended in obtaining and preparing samples prior to targeted analyses. It would be highly desirable to detect and quantify 1000s of analytes in such samples using comprehensive mass spectrometry techniques (e.g., SWATH and DIA) while retaining a high degree of quantitative rigor for analytes with matched internal standards. Experimentally, it is facile to port a targeted assay to a comprehensive data acquisition technique. However, data analysis challenges arise from this strategy concerning agreement of results from the targeted and comprehensive approaches. Here, we present the use of genetic algorithms to overcome these challenges in order to configure hybrid targeted/comprehensive MS assays. The genetic algorithms are used to select precursor-to-fragment transitions that maximize the agreement in quantification between the targeted and the comprehensive methods. We find that the algorithm we used provided across-the-board improvement in the quantitative agreement between the targeted assay data and the hybrid comprehensive/targeted assay that we developed, as measured by parameters of linear models fitted to the results. We also found that the algorithm could perform at least as well as an independently-trained mass spectrometrist in accomplishing this task. We hope that this approach will be a useful tool in the development of quantitative approaches for comprehensive proteomics techniques. Graphical Abstract ᅟ.

Entities:  

Keywords:  Algorithm; Computational proteomics; DIA; Genetic algorithm; Linear models; Mass Spectrometry; Modeling; Models; PRM; Proteomics; R; SWATH; Targeted proteomics

Mesh:

Year:  2016        PMID: 27562500      PMCID: PMC5061621          DOI: 10.1007/s13361-016-1465-2

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  19 in total

Review 1.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

2.  Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.

Authors:  Susan E Abbatiello; D R Mani; Hasmik Keshishian; Steven A Carr
Journal:  Clin Chem       Date:  2009-12-18       Impact factor: 8.327

3.  Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM).

Authors:  Sebastien Gallien; Sang Yoon Kim; Bruno Domon
Journal:  Mol Cell Proteomics       Date:  2015-03-09       Impact factor: 5.911

4.  A sentinel protein assay for simultaneously quantifying cellular processes.

Authors:  Martin Soste; Rita Hrabakova; Stefanie Wanka; Andre Melnik; Paul Boersema; Alessio Maiolica; Timon Wernas; Marco Tognetti; Christian von Mering; Paola Picotti
Journal:  Nat Methods       Date:  2014-09-07       Impact factor: 28.547

5.  Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes.

Authors:  Jennifer G Abelin; Jinal Patel; Xiaodong Lu; Caitlin M Feeney; Lola Fagbami; Amanda L Creech; Roger Hu; Daniel Lam; Desiree Davison; Lindsay Pino; Jana W Qiao; Eric Kuhn; Adam Officer; Jianxue Li; Susan Abbatiello; Aravind Subramanian; Richard Sidman; Evan Snyder; Steven A Carr; Jacob D Jaffe
Journal:  Mol Cell Proteomics       Date:  2016-02-24       Impact factor: 5.911

6.  A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

Authors:  Terri A Addona; Xu Shi; Hasmik Keshishian; D R Mani; Michael Burgess; Michael A Gillette; Karl R Clauser; Dongxiao Shen; Gregory D Lewis; Laurie A Farrell; Michael A Fifer; Marc S Sabatine; Robert E Gerszten; Steven A Carr
Journal:  Nat Biotechnol       Date:  2011-06-19       Impact factor: 54.908

7.  Building the Connectivity Map of epigenetics: chromatin profiling by quantitative targeted mass spectrometry.

Authors:  Amanda L Creech; Jordan E Taylor; Verena K Maier; Xiaoyun Wu; Caitlin M Feeney; Namrata D Udeshi; Sally E Peach; Jesse S Boehm; Jeannie T Lee; Steven A Carr; Jacob D Jaffe
Journal:  Methods       Date:  2014-11-06       Impact factor: 3.608

8.  Using iRT, a normalized retention time for more targeted measurement of peptides.

Authors:  Claudia Escher; Lukas Reiter; Brendan MacLean; Reto Ossola; Franz Herzog; John Chilton; Michael J MacCoss; Oliver Rinner
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

9.  Multiplexed MS/MS for improved data-independent acquisition.

Authors:  Jarrett D Egertson; Andreas Kuehn; Gennifer E Merrihew; Nicholas W Bateman; Brendan X MacLean; Ying S Ting; Jesse D Canterbury; Donald M Marsh; Markus Kellmann; Vlad Zabrouskov; Christine C Wu; Michael J MacCoss
Journal:  Nat Methods       Date:  2013-06-23       Impact factor: 28.547

10.  Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.

Authors:  Steven A Carr; Susan E Abbatiello; Bradley L Ackermann; Christoph Borchers; Bruno Domon; Eric W Deutsch; Russell P Grant; Andrew N Hoofnagle; Ruth Hüttenhain; John M Koomen; Daniel C Liebler; Tao Liu; Brendan MacLean; D R Mani; Elizabeth Mansfield; Hendrik Neubert; Amanda G Paulovich; Lukas Reiter; Olga Vitek; Ruedi Aebersold; Leigh Anderson; Robert Bethem; Josip Blonder; Emily Boja; Julianne Botelho; Michael Boyne; Ralph A Bradshaw; Alma L Burlingame; Daniel Chan; Hasmik Keshishian; Eric Kuhn; Christopher Kinsinger; Jerry S H Lee; Sang-Won Lee; Robert Moritz; Juan Oses-Prieto; Nader Rifai; James Ritchie; Henry Rodriguez; Pothur R Srinivas; R Reid Townsend; Jennifer Van Eyk; Gordon Whiteley; Arun Wiita; Susan Weintraub
Journal:  Mol Cell Proteomics       Date:  2014-01-17       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.